drugset / Trial / NCT00014677
NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme
Treatment
Summary
RATIONALE: NBI-3001 may be able to locate cancer cells and stop them from growing. This may be an effective treatment for glioblastoma multiforme. PURPOSE: Randomized phase II trial to compare different regimens of NBI-3001 followed by surgery to remove the tumor in treating patients who have glioblastoma multiforme.
Timeline
- Start
- 2001-03
- Primary completion
- 2002-09
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | interleukin-4 PE38KDEL cytotoxin | Protein / enzyme biologic | — | Other |